GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Inside one of those nondescript rooms last week, the Advisory Committee on Immunization Practices (ACIP), an independent ...

Key Takeaways High-risk adults as young as 50 are now eligible for the RSV vaccineThe update follows advice from now-deposed ...

Tests have identified Nipah virus in two patients from India’s Kerala state, one of them an 18-year-old woman from Malappuram ...

Stratified analyses revealed a notable increase in risk among cancer survivors aged 50 years or older at baseline (aHR, 1.85) ...